Abstract
The abstract presents results of the “InterQuality Project – International Research Project on Financing Quality in Healthcare” funded by the 7th Framework Programme (FP7) for Research and Technological Development of the European Union. Grant Agreement No: HEALTH-F3-2010-261369 Objectives: To identify, classify and assess indicators reflecting outcomes, efficiency, quality and equity of pharmaceutical care services from the perspective of three stakeholders: healthcare professionals, patients and payers as well as to describe them in accordance with Donabedian’s [1] and ECHO [2] models. Theory: Providing guidance for authorities seeking scientifically validated knowledge in the area of pharmaceutical care as a part of managed care is needed. Methods: A systematic review restricted to the last 10 years was conducted in Medline, Embase and the Cochrane Library. A non-systematic review was added. Results: 87 articles were identified during the systematic review and 10 publications were manually added. Indicators were assigned according to topic (efficiency, outcomes, quality and 13 th international Conference on Integrated Care, Berlin, Germany, April 11-12, 2013 2 International Journal of Integrated Care – Volume 13, 23 October – URN:NBN:NL:UI:10-1-114662– http://www.ijic.org/ equity), according to Donabedian’s model [1] as structure, process and outcomes indicators and according to ECHO model [2] as clinical intermediary, clinical outcomes, humanistic intermediary, humanistic and economic outcomes. Discussion: The indicators that are probably most useful for population-wide decision making are generic ones, as they allow comparisons between interventions. However, specific indicators are also sensible as they are more responsive to changes caused by interventions, and thus allow those changes to be measured. Conclusions: Our work provides a comprehensive overview and new classification of indicators ready to use for decision makers to help identify areas of outstanding quality in the area of pharmaceutical care.
Highlights
PhD, United BioSource Corporation, Lexington, MA, USA
A systematic review restricted to the last 10 years was conducted in Medline, Embase and the Cochrane Library
87 articles were identified during the systematic review and 10 publications were manually added
Summary
PhD, United BioSource Corporation, Lexington, MA, USA Szafraniec-Burylo, MD, PhD, Department -Centre for Monitoring and Analyses of Population Health Status and Health Care System, National Institute of Public Health, National Institute of Hygiene, Warsaw, Poland Marta Kowalczyk, MSc, Medical University of Warsaw, Poland
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.